Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
Author:
Affiliation:
1. Department of Medical Biology, School of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China
Publisher
Spandidos Publications
Subject
Cancer Research,Oncology
Reference43 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma;Wang;Int J Pharm,2015
3. Hepatocellular carcinoma, novel therapies on the horizon;El Dika;Chin Clin Oncol,2021
4. Challenges in liver cancer and possible treatment approaches;Anwanwan;Biochim Biophys Acta Rev Cancer,2020
5. Epithelial mesenchymal and endothelial mesenchymal transitions in hepatocellular carcinoma: A review;Gurzu;Biomed Res Int,2019
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study;Journal of Cancer Research and Clinical Oncology;2024-08-18
2. Expression of LASS2 Can be Regulated by Dihydroartemisinin to Regulate Cisplatin Chemosensitivity in Bladder Cancer Cells;Current Pharmaceutical Biotechnology;2024-05-16
3. NiWo4- RGO composite exerts cytotoxic effects on pancreatic carcinoma cells via a cross-talk between reactive oxygen species-independent canonical autophagy of the mitochondria and epithelial-mesenchymal transition;Journal of Drug Delivery Science and Technology;2024-05
4. Copper Chaperone Atox1 Protected the Cochlea From Cisplatin by Regulating the Copper Transport Family and Cell Cycle;International Journal of Toxicology;2023-10-20
5. PD-1/PD-L1 Interaction Upregulates YAP1 Expression in HepG2 Cells Through MAPK/ERK Pathway;Natural Product Communications;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3